Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY® (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER

SUZHOU, China, Dec. 21, 2021 /PRNewswire/ -- CStone Pharmaceuticals (the " Company" or "CStone") is pleased to announce that the National Medical Products Administration ("NMPA") of China has approved the new drug application ("NDA") of anti-PD-L1 monoclonal antibody Cejemly® (sugemalimab) in comb...

2021-12-21 16:56 2638

Huihe Healthcare Completes First K-Clip Treatment in Hong Kong

HONG KONG, Dec. 21, 2021 /PRNewswire/ -- The first successful Transcatheter Tricuspid Annulus repair using a K-Clip has taken place outside ofChina. The treatment took place onDecember 19th 2021 at Hong Kong's HK Asia Heart Centre. The treatment is a minimally invasive treatment of mitral and tri...

2021-12-21 15:00 2451

Transform and Evolve: Uniview 3rd Global Partner Summit Recap

HANGZHOU, China, Dec. 21, 2021 /PRNewswire/ -- Uniview held its 3rd Global Partner Summit "Transform. Evolve." in the form of live streaming during its 10 th Anniversary. The invitation-only virtual event featured discussions on how surveillance industry can tackle the challenges after COVID-19 – ...

2021-12-21 13:37 2568

Hettigoda Industries Private Limited Awarded at the International Innovation Awards 2021 for Siddhalepa Pain Relief Spray

SINGAPORE, Dec. 20, 2021 /PRNewswire/ -- Enterprise Asia is pleased to honor 52 award recipients at the International Innovation Awards 2021. Spearheading the Innovation Revolution, the International Innovation Awards which aims to create an innovation ecosystem for enterprises is held annually...

2021-12-21 11:53 1554

The Clinician joins AWS ISV Accelerate Program

AUCKLAND, New Zealand, Dec. 21, 2021 /PRNewswire/ -- The Clinician , a global digital health leader, announced today that it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate program. The AWS ISV Accelerate Program is a co-sell progr...

2021-12-21 08:40 2456

The New Era Biotechnology Brings The Cooperation Between China And Belarus To A New Level

MINSK, Belarus, Dec. 21, 2021 /PRNewswire/ -- New Era Biotechnology Co., Ltd is an enterprise fromthe Great Stone China Belarus Industrial Park (CBIP) in Minsk . It participated in the fourth edition of the China International Import Expo (CIIE) which opened inShanghai on November 5, 2021. Loc...

2021-12-21 08:04 2214

The New Era Biotechnology Brings The Cooperation Between China And Belarus To A New Level

World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine

- Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO - EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketedby Serum Institute of India as Covovax™ - EUL by WHO is a prerequisite for exports to numerous countri...

2021-12-21 03:33 2551

European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

* Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine authorized for use inEurope * Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 * Authorization follows positive r...

2021-12-21 03:28 2670

Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine

* European Commission decision on conditional marketing authorization expected imminently * Upon authorization, Nuvaxovid™ (also known as NVX-CoV2373) will be the first protein-based COVID-19 vaccine available inEurope GAITHERSBURG, Md., Dec. 20, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NV...

2021-12-20 21:34 2433

Everest Medicines and Providence Therapeutics announces that PTX-COVID19-B, a mRNA Vaccine for COVID-19, has received approval for inclusion in WHO Solidarity Trial Vaccines (STV) Program

SHANGHAI, Dec. 20, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) and Providence Therapeutics ("Providence") announced today that their COVID-19 vaccine, PTX-COVID19-B, has been recommended by an independent advisory group to be part of the WHO Solidarity Trial Vaccines ("STV") clinical t...

2021-12-20 20:55 2892

Thailand BOI Approves Extension of Investment Acceleration Package, EEC Incentive Package and Additional Special Zones

BANGKOK, Dec. 20, 2021 /PRNewswire/ -- The Thailand Board of Investment (BOI) at a meeting today approved a number of policy measures, namely an extension of the investment acceleration package and EEC incentive package, special incentive package for Yothi Medical Innovation Zone and classificati...

2021-12-20 20:49 2209

Thailand BOI Approves Extension of Investment Acceleration Package, EEC Incentive Package and Additional Special Zones

2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices

* Report developed as per Global Reporting Initiative (GRI) standards * Extensively deals with the company's response to the Covid-19 pandemic HYDERABAD, India, Dec. 20, 2021 /PRNewswire/ -- Sai Life Sciences, a leading globalContract Research, Development & Manufacturing Organization

2021-12-20 19:16 803

2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices

Syntach AB awarded an EU grant of € 2.5 million

LUND, Sweden, Dec. 20, 2021 /PRNewswire/ -- Syntach AB in Lund, Sweden has been awarded € 2.5 million as a grant and part of blended finance of up to € 17,5 million from the European Innovation Council (EIC) to support the development of its unique minimally invasive cardiac support system. Over...

2021-12-20 15:00 1914

The Korea Ginseng Association Introduces Literature Review on Effects of Korean Ginseng in Cancer Treatment

SEOUL, South Korea, Dec. 20, 2021 /PRNewswire/ -- Cancer is one of the leading causes of death worldwide, which leads to symptoms such as pain, lethargy, and shortness of breath, reducing the patient's quality of life and causing excruciating pain. The Korea Ginseng Association has introduced a l...

2021-12-20 12:07 2026

The Korea Ginseng Association Introduces Literature Review on Effects of Korean Ginseng in Cancer Treatment

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

SHANGHAI and HONG KONG, Dec. 20, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...

2021-12-20 11:01 3209

Japan's MHLW Approves Booster Shot for SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine

The SPIKEVAX® brand name was developed in partnership with Brand Institute, the global leader in pharmaceutical and healthcare-related name development MIAMI, Dec. 20, 2021 /PRNewswire/ -- Brand Institute is proud to announce its successful partnership with Moderna in naming their mRNA COVID-19 v...

2021-12-20 09:00 2444

Novo Nordisk topping the list of Best Places to Work in Bangladesh for 2021

DHAKA, Bangladesh, Dec. 20, 2021 /PRNewswire/ -- Novo Nordisk Bangladesh, an affiliate of the global healthcare company with more than 95 years of innovation and leadership in diabetes care, has recently been recognized as the Best Place to Work inBangladesh for 2021. During the assessment, the ...

2021-12-20 09:00 1712

Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine

* First EUL granted by WHO for a protein-based COVID-19 vaccine * EUL vaccine manufactured and marketed by SII as COVOVAX™ * WHO EUL for Nuvaxovid™ currently under assessment; will be completed following European Medicines Agency (EMA) review GAITHERSBURG, Md. and PUNE, India, Dec. 20, 2021 ...

2021-12-20 08:24 2220

Novo Nordisk among the top 3 Best Places to Work in Singapore for 2021

Singapore, Dec. 20, 2021 Novo Nordisk Singapore, an affiliate of the global healthcare company with more than 95 years of innovation and leadership in diabetes care, has recently been recognized among the top 3 Best Places to Work for 2021. During the assessment, the company received outsta...

2021-12-20 07:25 1712

Antengene Announces NDA Approval by NMPA for XPOVIO®, China's First XPO1 inhibitor, for the Treatment of Adults with Relapsed or Refractory Multiple Myeloma

SHANGHAI and HONG KONG, Dec. 17, 2021 /PRNewswire/ -- Antengene Corporation Limited (the "Company" or "Antengene") is pleased to announce thatATG-010 (selinexor, brand name:XPOVIO®), a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound has received conditional approval for...

2021-12-17 22:27 4902

1 ... 244 245 246247248 249 250 ... 553